The COVID-19 pandemic changed the patterns of internal population movements around the world. Existing work has focused on countries in the Global North and has been limited to the immediate effects of COVID-19, using data from 2020. The lack of data has been a significant limitation in analyzing changes in mobility patterns within of the countries of the Global South, including Latin America. Using aggregated and anonymized mobile phone location data from Meta-Facebook users, we aim to analyze the impact and persistence of the pandemic on the intensities and patterns of internal population movements across the urban hierarchy. in Argentina, Chile and Mexico over a 26-month period, from March 2020 to May 2022. Our results reveal a systematic and widespread decrease in the intensity of short- and long-distance movements during periods with high levels of restrictions in 2020 , with greater reductions in the most densely populated areas in the capital cities. We also show that, in 2022, after the relaxation of restriction measures, intensities increased, approaching those recorded before the pandemic. However, at average levels they have remained below pre-pandemic levels even in 2022. Our findings support, to a certain extent, the hypothesis of an urban exodus, as they reveal the persistence of negative net balances in short-distance movements in the capitals of Argentina and Mexico, reflecting a pattern of suburbanization. Chile does not show substantial changes in the net balance of short-distance movements, but registers net losses in long-distance movements. These losses were, however, temporary, moving to neutral or positive balances in 2021 and 2022. This contrasts with the pattern of net migration losses observed in the Santiago Metropolitan Region in the last 20 years.
health
Amato trial, the defense asks for acquittal: “The fact does not exist”
Bologna, 1 October 2024 – La defense by Giampaolo Amato comes out to ask to the Court of Assizes “convincedly and firmly the acquittal of the accused Why the fact does not existgiven that no accusation has been proven beyond a reasonable doubt.” It’s discussion time for the defenders of the 65-year-old doctor accused of killing his wife Isabella Lsala e mother-in-law Giulia Tateo 22 days apart in October 2021, with a cocktail of medications. In aula is also present the son of the accusedNicola, for the first time if we exclude the day of his testimony.
Lawyer Gianluigi Lebro begins: “The mere plausibility of an alternative reconstruction for the contested facts with only evidence requires acquittal,” he clarifies. And he proceeds to reply one by one to the themes contested by the prosecution.
The motive. “Giampaolo Amato wasn’t right commit those crimes. The your unique guilt was manage his extramarital affair in the worst possible waytrying to maintain a balance between the passion for the lover and the bond with the family: he didn’t succeed. The economic motive does not exist, he never needed money. And not even the sentimental one, given that in October 2021 he had already left home and could do whatever he wanted.”
The points analyzed. The cremation, the blankets tucked in to the now dead Isabella, the famous bottle offered at dinner by Amato to his wife and kept since 2019 by the victim’s sister, then analyzed in 2022 by the Ris, which tested positive for Midazolam, the benzodiazepine which for the prosecution is was lethal to the two women. The lawyer Lebro on this last point insists e shows in the courtroom the resealable cap with which the bottle had been closed: “The discovery of Midazolam in Isabella’s body was made known to the parties before the analysis of the bottle. Which was certainly not sealed in a manner suitable for an element of evidence, albeit indirect, decisive for a murder trial”, attacks the lawyer. And the blankets? “The 118 doctor tucked her in after the first visit to Isabella’s body to check there were no traces of violence”.
As for the drugs (Amato is also accused of embezzlement for having stolen them from one of the ASL hospitals where he worked), Lebro glosses: “There is no proof of this. And in the same way that he could theoretically have taken them, his wife could have stolen them from the clinics where she worked. It is an abstract possibility that applies both ways. And so, a possible alternative reconstruction exists. We therefore ask the Court to restore Giampaolo Amato to the life he has left, where he will find at least his children waiting for him, from whom he has taken away neither their mother nor their grandmother.”
It is now the turn of the other defense lawyer, Cesarina Mitaritonna.
According to the IDF Diabetes Atlas, there are 537 million people living with diabetes worldwide. More than 90% of them have type 2 diabetes, and nearly half are undiagnosed. It is expected that by 2030 this will increase to 643 million and by 2045 it will increase to 783 million.
While the diabetes situation in Thailand Data from public health statistics reports Ministry of Public Health Thailand has found that the incidence of diabetes tends to continually increase. In 2023, there will be 300,000 new patients per year. In 2022, there will be 3.3 million people with diabetes, an increase from 2012. In 2021, up to 150,000 people for screening new patients in 2023 found that screening for diabetes patients in people aged 35 years and over has not been screened.Diabetesup to 5 million people from a nationwide target of 22 million people
Related news:
“Diabetes” is a health problem for Thai people. That’s not very dangerous.
The pharmaceutical industry is growing rapidly. 5.2 million Thai people have diabetes.
Current guidelines for treating diabetes
Clinical Prof. Dr. Chaichan Deerojanawong, President of the Endocrine Society of Thailand Revealed that diabetes has always been an important problem for Thai people. Especially in an era where people’s lives have become more convenient. As a result, there are an increasing number of people with diabetes every year.
DiabetesIt is caused by abnormalities in the body’s ability to transport glucose into cells due to insulin deficiency and/or insulin resistance. As a result, blood sugar levels rise. Controlling blood sugar levels close to normal inpatientDiabetes is important in reducing the risk of complications. Diabetes includes kidney failure, blindness, and cardiovascular disease.
There are many ways to care for diabetes today, including diet control. exercise and use of drugs to reduce blood sugar levels These methods are important in helping to control blood sugar levels within normal limits. But at the same time, adjustments must be made to suit each patient individually because patients have different blood sugar levels and co-factors. Nowadays there are new medicines. That can be an option for effective diabetes care.
Innovative medicine for treating diabetes
During the initial period of treatmentDiabetesInsulin injections and sulfonylurea tablets are used to lower blood sugar levels. The main disadvantage of the above two groups of drugs is the occurrence of hypoglycemia and weight gain after treatment. In addition, there is metformin tablets, which do not cause hypoglycemia and weight gain. climb Nowadays, there are new innovative medicines. that is continuously developed in the treatment of diabetes Especially in the group that is an oral medicine. This is an option for patients who are not comfortable using injection methods, including:
1. GLP-1 Receptor Agonists
GLP-1 Receptor Agonists work by stimulating the GLP-1 receptor, which is the same hormone that is produced in the intestines in the body. Makes blood sugar levels decrease The medicine only works when there is high blood sugar. Therefore, it will not increase the risk of hypoglycemia in the blood. In addition, it can also help in weight loss, which is an important advantage for diabetic patients who often have problems with being overweight.
This group of drugs is also useful in reducing the risk of cardiovascular disease. Therefore, this is a feature that makes GLP-1 Receptor Agonists an attractive alternative. This is especially true for patients at high risk of cardiovascular disease. In addition, recent data has shown that it can slow down kidney deterioration in diabetic patients as well.
Recently, GLP-1 Receptor Agonists have evolved from their original form. which is an injection and comes as an oral drug that has similar efficacy This is a breakthrough that represents a new innovation that gives patients more convenient treatment options.
2. SGLT2 Inhibitors
SGLT2 Inhibitors play a role in controlling blood sugar levels. By inhibiting the reabsorption of sugar by the kidneys. Causes the body to excrete sugar with urine. This group of drugs does not cause hypoglycemia and has the advantage of reducing the risk of heart disease and slowing down the deterioration of the kidneys. It is considered another option for treating diabetes.
3. DPP-4 Inhibitors
DPP-4 Inhibitors work by blocking the DPP-4 enzyme, which is the enzyme that breaks down the hormone GLP-1 in the body. DPP-4 Inhibitors have the advantage of not increasing the risk of hypoglycemia. But this group of drugs has no effect on body weight and has no direct effect on reducing the risk of heart disease and kidney disease.
Research progress in Thailand
Clinical research is extremely important to doctors andpatient Especially in the context of Thailand Clinical research that is specific to the Thai population It not only helps to understand needs and problems.healthof patients but can also develop more appropriate and effective treatment guidelines
innovationdiabetes medicinein Thailand at present It has affected patient care by increasing treatment options that suit individual needs. This is considered an important advancement that should be supported and developed continuously. But these are the only good developments. Probably not enough to prevent diabetes.
Controlling your diet and exercising regularly It remains the main strategy for effective prevention and treatment of diabetes. Understanding the consumption of types and quantities of food Changing lifestyle habits will also help reduce the risk of diabetes complications.
however innovationNew medicines for treating diabetes and consuming the right food along with regular exercise Therefore, it is the key to helping manage diabetes in Thailand.
National Day of Italian Historic Hospitals (ACOSI) in Romagna
The Third National Day of Historic Italian Hospitals will be celebrated throughout Italy on Sunday 13 October 2024.
All the hospitals in the ACOSI network will open their monumental spaces to the public, offering visitors guided tours and free concerts. In the spirit of the Association, the initiative enhances an illustrious history of science, charity and art, to promote innovative practices in healthcare, which integrate cultural, scientific, architectural and operational aspects.
The Romagna Local Health Authority, with its Widespread museum of Romagna healthcare art – Care through Artjoined the Associazione Culturale Ospedali Storici Italiani (ACOSI), founded in 2019, in 2021.
“Aware that art and creative activities have a strong impact on our “well-being” – explains Dr. Sonia Muzzarelli, curator of the historical-artistic heritage of the Romagna Local Health Authority – the Romagna Local Health Authority, in this third event dedicated to historic Italian hospitals, will present its operators in different roles. They will be the protagonists of the various musical moments, and not only that, which will mark the day of the historic hospitals”
The program of the Romagna Local Health Authority for Historic Hospitals Day (13 October) includes guided tours, exhibitions, concerts and readings at the historic hospitals of Faenza – Ospedale degli Infermi, of Forlì – GB Morgagni L. Pierantoni Hospital and finally the pharmacy of the old hospital and the Oratory of Sant’Onofrio in Lugo di Romagna:
Faenza – Hospital of the Sick Corso Mazzini, 136
Meeting at 10.15am, at the Galleria delle Colonne, at the foot of the monumental staircase of the hospital
Greetings from the Director of the Presidium Dr. Davide Tellarini
Small musical moment by the Faenza Hospital choir (made up of healthcare workers) who will perform a surprise program
To follow, guided tour conduct dto Dr. Sonia Muzzarelli and the Arch. Andrea Gozzoli
Forlì – GB Morgagni L. Pierantoni Hospital, Via C. Forlanini, 34
– Meeting at 3.00 pm in the hospital lobby, Morgagni Pavilion
Greetings from the Director of the Forlì Presidium, Dr. Giorgio Martelli
Presentation of the initiative by Dr. Sonia Muzzarelli
Small musical moment:
Piano: Francesco Girelli – Head of Rheumatology
Violin: Ioana Luminita Tudosa – Nurse
They will interpret:
-“Canon in D major” by Johann Pachelbel (1653-1706)
-Theme from: “The witches op.8” by Nicolò Paganini (1782-1840)
-“Everybody hurts” dei R.E.M. 1992
– 3.30 pm Guided tour of the Hospital Park conducted by local history historian Gabriele Zelli
– 4.30 pm, in front of the Allende pavilion, the architect of the ASL Romagna, Gianni Bisulli and the Arch. Marcello Balzani, will present the historic pavilions of Forlì
5.00 pm: small musical space by the duo “Due Note”:
Piano: Dr. Massimo Fiori
Soprano: Vera della Scala
they will perform a selection of songs from famous film soundtracks
from 3.00 pm to 5.30 pm, At the entrance to the Morgagni Pierantoni Hospital, the ASL employees will be available to tell you about the secret beauties of the Hospital Park: Antonella Guerra (amateur botany researcher), Leonardo Colonnello and Ivan Versari (greenery experts from the Forlì Presidium)
In case of rain, the event will take place in the Atrium of the Forlì Hospital
Lugo di Romagna
Oratory of Sant’Onofrio, Largo Calderoni, 3
Extraordinary daily opening from 10.00am for inauguration Juke Book vintagand adapted for listening to readings aloud – edited by the Trisi Library of Lugo (Ra)
Old Hospital Pharmacy, Corso Mazzini 11
Extraordinary daily opening from 10.00am
with exhibition on the occasion of Lugo Vintage Festival